The FDA occupies a unique position at the intersection of science, medicine, public health, and innovation. Patients depend on the agency to evaluate therapies rigorously and fairly; innovators depend on predictable regulatory pathways; and investors depend on confidence that scientific evidence will guide decision-making.
Restoring trust in the FDA will require a sustained commitment to transparency, consistency, scientific integrity, accountability, and modernization. If the agency can achieve those goals, it will strengthen both public health and America’s leadership in biomedical innovation. Recovery at the FDA will help ensure that lifesaving science translates to the public good through a process worthy of public trust. As pioneering microbiologist Louis Pasteur advised 140 years ago, “Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence.”
